Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Other Accumulated Expenses (2017 - 2025)

Catheter Precision (VTAK) has disclosed Other Accumulated Expenses for 8 consecutive years, with $36000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 25.0% to $36000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $36000.0, a 25.0% decrease, with the full-year FY2024 number at $76000.0, down 67.24% from a year prior.
  • Other Accumulated Expenses was $36000.0 for Q3 2025 at Catheter Precision, up from $27000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $575000.0 in Q4 2021 to a low of $27000.0 in Q2 2025.
  • A 5-year average of $208625.0 and a median of $159500.0 in 2022 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: grew 13.41% in 2021, then tumbled 71.88% in 2025.
  • Catheter Precision's Other Accumulated Expenses stood at $575000.0 in 2021, then plummeted by 35.3% to $372000.0 in 2022, then crashed by 37.63% to $232000.0 in 2023, then tumbled by 67.24% to $76000.0 in 2024, then plummeted by 52.63% to $36000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Other Accumulated Expenses are $36000.0 (Q3 2025), $27000.0 (Q2 2025), and $72000.0 (Q1 2025).